Clinical Trial Update: A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy combined with paclitaxel and carboplatin for uterine papillary serous carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Cancer
• Uterine Papillary Serous Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Uterine Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12